Independent Action Models and Prediction of Combination Treatment Effects for Response Rate, Duration of Response and Tumor Size Change in Oncology Drug Development

by   Linda Z. Sun, et al.

An unprecedented number of new cancer targets are in development, and most are being developed in combination therapies. Early oncology development is strategically challenged in choosing the best combinations to move forward to late stage development. The most common early endpoints to be assessed in such decision-making include objective response rate, duration of response and tumor size change. In this paper, using independent-drug-action and Bliss-drug-independence concepts as a foundation, we introduce simple models to predict combination therapy efficacy for duration of response and tumor size change. These models complement previous publications using the independent action models (Palmer 2017, Schmidt 2020) to predict progression-free survival and objective response rate and serve as new predictive models to understand drug combinations for early endpoints. The models can be applied to predict the combination treatment effect for early endpoints given monotherapy data, or to estimate the possible effect of one monotherapy in the combination if data are available from the combination therapy and the other monotherapy. Such quantitative work facilitates efficient oncology drug development.



There are no comments yet.


page 1

page 2

page 3

page 4


A multistate model for early decision making in oncology

The development of oncology drugs progresses through multiple phases, wh...

A Node Embedding Framework for Integration of Similarity-based Drug Combination Prediction

Motivation: Drug combination is a sensible strategy for disease treatmen...

Synergistic Drug Combination Prediction by Integrating Multi-omics Data in Deep Learning Models

Drug resistance is still a major challenge in cancer therapy. Drug combi...

Prediction of Drug Synergy by Ensemble Learning

One of the promising methods for the treatment of complex diseases such ...

REP: Predicting the Time-Course of Drug Sensitivity

The biological processes involved in a drug's mechanisms of action are o...

Application of Kriging Models for a Drug Combination Experiment on Lung Cancer

Combinatorial drugs have been widely applied in disease treatment, espec...

Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth

Prostate cancer can be lethal in advanced stages, for which chemotherapy...
This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.